327 related articles for article (PubMed ID: 23428230)
1. Determinants and associated factors influencing medication adherence and persistence to oral anticancer drugs: a systematic review.
Verbrugghe M; Verhaeghe S; Lauwaert K; Beeckman D; Van Hecke A
Cancer Treat Rev; 2013 Oct; 39(6):610-21. PubMed ID: 23428230
[TBL] [Abstract][Full Text] [Related]
2. Adherence influencing factors in patients taking oral anticancer agents: a systematic review.
Mathes T; Pieper D; Antoine SL; Eikermann M
Cancer Epidemiol; 2014 Jun; 38(3):214-26. PubMed ID: 24768601
[TBL] [Abstract][Full Text] [Related]
3. The effectiveness of therapeutic patient education on adherence to oral anti-cancer medicines in adult cancer patients in ambulatory care settings: a systematic review.
Arthurs G; Simpson J; Brown A; Kyaw O; Shyrier S; Concert CM
JBI Database System Rev Implement Rep; 2015 Jun; 13(5):244-92. PubMed ID: 26455611
[TBL] [Abstract][Full Text] [Related]
4. Patient adherence to oral anticancer drugs: an emerging issue in modern oncology.
Foulon V; Schöffski P; Wolter P
Acta Clin Belg; 2011; 66(2):85-96. PubMed ID: 21630604
[TBL] [Abstract][Full Text] [Related]
5. Adherence and patients' experiences with the use of oral anticancer agents.
Timmers L; Boons CC; Kropff F; van de Ven PM; Swart EL; Smit EF; Zweegman S; Kroep JR; Timmer-Bonte JN; Boven E; Hugtenburg JG
Acta Oncol; 2014 Feb; 53(2):259-67. PubMed ID: 24266637
[TBL] [Abstract][Full Text] [Related]
6. Patient adherence and persistence with oral anticancer treatment.
Ruddy K; Mayer E; Partridge A
CA Cancer J Clin; 2009; 59(1):56-66. PubMed ID: 19147869
[TBL] [Abstract][Full Text] [Related]
7. Factors Influencing Adherence in Cancer Patients Taking Oral Tyrosine Kinase Inhibitors: A Qualitative Study.
Verbrugghe M; Duprez V; Beeckman D; Grypdonck M; Quaghebeur M; Verschueren C; Verhaeghe S; Van Hecke A
Cancer Nurs; 2016; 39(2):153-62. PubMed ID: 25815430
[TBL] [Abstract][Full Text] [Related]
8. Adherence enhancing interventions for oral anticancer agents: a systematic review.
Mathes T; Antoine SL; Pieper D; Eikermann M
Cancer Treat Rev; 2014 Feb; 40(1):102-8. PubMed ID: 23910455
[TBL] [Abstract][Full Text] [Related]
9. Medication adherence to oral anticancer drugs: systematic review.
Huang WC; Chen CY; Lin SJ; Chang CS
Expert Rev Anticancer Ther; 2016; 16(4):423-32. PubMed ID: 26935964
[TBL] [Abstract][Full Text] [Related]
10. Factors influencing oral adherence: qualitative metasummary and triangulation with quantitative evidence.
Johnson LA
Clin J Oncol Nurs; 2015 Jun; 19(3 Suppl):6-30. PubMed ID: 26030389
[TBL] [Abstract][Full Text] [Related]
11. The Association Between Patient-Reported and Objective Oral Anticancer Medication Adherence Measures: A Systematic Review
.
Atkinson TM; Rodríguez VM; Gordon M; Avildsen IK; Emanu JC; Jewell ST; Anselmi KA; Ginex PK
Oncol Nurs Forum; 2016 Sep; 43(5):576-82. PubMed ID: 27541550
[TBL] [Abstract][Full Text] [Related]
12. Assessing the need for improved strategies and medication-related education to increase adherence for oral anticancer medications in the young adult oncology population.
Divakaruni A; Saylor E; Duffy AP
J Oncol Pharm Pract; 2018 Jul; 24(5):337-342. PubMed ID: 28387636
[TBL] [Abstract][Full Text] [Related]
13. Adherence, compliance and persistence to oral antineoplastic therapy: a review focused on chemotherapeutic and biologic agents.
Gebbia V; Bellavia G; Ferraù F; Valerio MR
Expert Opin Drug Saf; 2012 May; 11 Suppl 1():S49-59. PubMed ID: 22149481
[TBL] [Abstract][Full Text] [Related]
14. A review of factors influencing non-adherence to oral antineoplastic drugs.
Skrabal Ross X; Gunn KM; Suppiah V; Patterson P; Olver I
Support Care Cancer; 2020 Sep; 28(9):4043-4050. PubMed ID: 32335731
[TBL] [Abstract][Full Text] [Related]
15. Psychosocial determinants of adherence with oral anticancer treatment: 'we don't need no education'.
Kaptein AA; Schoones JW; van der Meer PB; Matsuda A; Murray M; Heimans L; Kroep JR
Acta Oncol; 2021 Jan; 60(1):87-95. PubMed ID: 33151764
[TBL] [Abstract][Full Text] [Related]
16. Adherence to Oral Anticancer Therapeutics in the Gynecologic Oncology Population.
Watson CH; Fish LJ; Falkovic M; Monuszko K; Lorenzo A; Havrilesky LJ; Secord AA; Davidson BA
Obstet Gynecol; 2020 Dec; 136(6):1145-1153. PubMed ID: 33156183
[TBL] [Abstract][Full Text] [Related]
17. Non-conventional dosing of oral anticancer agents in oncology and malignant haematology: a systematic review protocol.
Djebbari F; Stoner N; Lavender V
Syst Rev; 2017 Dec; 6(1):244. PubMed ID: 29208047
[TBL] [Abstract][Full Text] [Related]
18. Theoretical foundations of adherence behaviors: synthesis and application in adherence to oral oncology agents.
Irwin M
Clin J Oncol Nurs; 2015 Jun; 19(3 Suppl):31-5. PubMed ID: 26030390
[TBL] [Abstract][Full Text] [Related]
19. Patient-reported factors associated with adherence to adjuvant endocrine therapy after breast cancer: an integrative review.
Lambert LK; Balneaves LG; Howard AF; Gotay CC
Breast Cancer Res Treat; 2018 Feb; 167(3):615-633. PubMed ID: 29110151
[TBL] [Abstract][Full Text] [Related]
20. Exploring the factors influencing adherence to oral anticancer drugs in patients with digestive cancer: a qualitative study.
Nizet P; Touchefeu Y; Pecout S; Cauchin E; Beaudouin E; Mayol S; Fronteau C; Huon JF
Support Care Cancer; 2022 Mar; 30(3):2591-2604. PubMed ID: 34812952
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
